IL-17 contributes to the initiation of carcinogenesis since the neutralization of IL-17 prevented early neoplastic lesion formation (pancreatic intraepithelial neoplasia (PanIN), which can progress to invasive ductal adenocarcinoma), while forced IL-17 expression accelerated PanIN formation and progression. This evidence concerns the gene IL17A and invasive ductal breast carcinoma.